Radiopharm Theranostics Files 6-K Update
Ticker: RDPTF · Form: 6-K · Filed: Feb 25, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Radiopharm Theranostics filed a routine 6-K update with the SEC on Feb 25, 2025.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on February 25, 2025, reporting information for the month of February 2025. The company is a foreign private issuer and is providing updates as required by the SEC. The filing does not contain specific financial figures or significant operational announcements within the provided text.
Why It Matters
This filing indicates ongoing reporting compliance by Radiopharm Theranostics, which is crucial for maintaining transparency with investors and regulators.
Risk Assessment
Risk Level: low — The filing is a standard regulatory report and does not contain information that inherently increases risk.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- February 2025 (date) — Reporting Period
- 20250225 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of its home country, or which it furnishes or is required to furnish to its security holders.
What is the SEC file number for Radiopharm Theranostics Limited?
The SEC file number for Radiopharm Theranostics Limited is 001-41621.
When was this Form 6-K filed?
This Form 6-K was filed on February 25, 2025.
Is Radiopharm Theranostics Limited filing an annual report under Form 20-F?
Yes, the filing indicates that the registrant files annual reports under cover of Form 20-F.
What is the principal executive office address of Radiopharm Theranostics Limited?
The principal executive office address is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 25, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).